Vigil Neuroscience, Inc./$VIGL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Vigil Neuroscience, Inc.

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

Ticker

$VIGL
Primary listing

Industry

Biotechnology

Employees

67

ISIN

US92673K1088

VIGL Metrics

BasicAdvanced
$371M
-
-$2.05
3.45
-

Bulls say / Bears say

Sanofi's acquisition of Vigil Neuroscience for $470 million, including a $2 per share contingent value right tied to the progress of VG-3927, underscores strong confidence in Vigil's Alzheimer's drug pipeline. (reuters.com)
Positive Phase 1 data for VG-3927 demonstrated a favorable safety profile and significant target engagement, supporting its advancement into Phase 2 trials for Alzheimer's treatment. (vigilneuro.com)
Vigil's strategic focus on microglial function restoration positions it uniquely in the neurodegenerative disease market, potentially leading to innovative therapies. (vigilneuro.com)
Vigil reported a net loss of $84.3 million for the year ended December 31, 2024, indicating ongoing financial challenges. (vigilneuro.com)
The company's cash, cash equivalents, and marketable securities decreased to $97.8 million as of December 31, 2024, from $117.9 million the previous year, reflecting a declining cash position. (vigilneuro.com)
Vigil's total liabilities increased to $46.1 million as of December 31, 2024, up from $24.6 million the previous year, indicating rising financial obligations. (vigilneuro.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VIGL

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs